Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 7Colorectal Neoplasms 3Carcinoma, Renal Cell 3Pancreatic Neoplasms 2Myelodysplastic Syndromes 2Multiple Myeloma 2Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Clear-cell metastatic renal cell carcinoma 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Triple Negative Breast Neoplasms 1Thrombocytosis 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Synovial 1Sarcoma, Clear Cell 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Rhabdomyosarcoma 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neurofibrosarcoma 1Neuroblastoma 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Mouth Neoplasms 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

zanubrutinib 3Rituximab 3Bendamustine Hydrochloride 3ibrutinib 2talquetamab 1pirtobrutinib 1Sra protein, Drosophila 1Specimen Handling 1Sirolimus 1Prednisone 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Everolimus 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Waldenstrom Macroglobulinemia × Biopsy × Clear all
NCT07420959 2026-02-19

ABBV-383 for the Treatment of Relapsed Refractory Waldenström Macroglobulinemia

Mayo Clinic

Phase 1/2 Not yet recruiting
38 enrolled
Lymphoid

Waldenstrom Macroglobulinemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡